BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 11276271)

  • 1. Therapeutic options in nonulcer dyspepsia.
    Talley NJ
    J Clin Gastroenterol; 2001 Apr; 32(4):286-93. PubMed ID: 11276271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional dyspepsia. Current treatment recommendations.
    Holtmann G; Talley NJ
    Drugs; 1993 Jun; 45(6):918-930. PubMed ID: 7691499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the role of drug therapy in non-ulcer dyspepsia.
    Talley NJ
    Rev Gastroenterol Disord; 2003; 3(1):25-30. PubMed ID: 12684590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New considerations in the treatment of functional dyspepsia].
    Herszényi L; Juhász M; Tulassay Z
    Orv Hetil; 2004 Apr; 145(14):747-54. PubMed ID: 15131990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Functional dyspepsia: the past, the present and the Rome III classification].
    Buzás GM
    Orv Hetil; 2007 Aug; 148(33):1573-9. PubMed ID: 17686677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group.
    Champion MC; MacCannell KL; Thomson AB; Tanton R; Eberhard S; Sullivan SN; Archambault A
    Can J Gastroenterol; 1997 Mar; 11(2):127-34. PubMed ID: 9113812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of gastric function and prevalence of Helicobacter pylori in non-ulcer dyspepsia].
    Takayasu H; Harasawa S; Miwa T; Yamada Y
    Nihon Shokakibyo Gakkai Zasshi; 1993 Apr; 90(4):743-54. PubMed ID: 8492467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia.
    Sakaguchi M; Takao M; Ohyama Y; Oka H; Yamashita H; Fukuchi T; Ashida K; Murotani M; Murotani M; Majima K; Morikawa H; Hashimoto T; Kiyota K; Esaki H; Amemoto K; Isowa G; Takao F
    World J Gastroenterol; 2012 Apr; 18(13):1517-24. PubMed ID: 22509084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of effect of Helicobacter pylori on symptom improvement with a prokinetic medication, cisapride, in patients with non-ulcer dyspepsia.
    Gonlachanvit S; Mahachai V; Chaiwatanarat T; Kullavanijaya P
    J Med Assoc Thai; 2005 May; 88(5):660-7. PubMed ID: 16149685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyspepsia: current understanding and management.
    Agréus L; Talley NJ
    Annu Rev Med; 1998; 49():475-93. PubMed ID: 9509276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional dyspepsia: new insights into pathogenesis and therapy.
    Talley NJ
    Korean J Intern Med; 2016 May; 31(3):444-56. PubMed ID: 27048251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis.
    Veldhuyzen van Zanten SJ; Jones MJ; Verlinden M; Talley NJ
    Am J Gastroenterol; 2001 Mar; 96(3):689-96. PubMed ID: 11280535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in patients' symptoms and gastric emptying after Helicobacter pylori treatment.
    Zhang CL; Geng CH; Yang ZW; Li YL; Tong LQ; Gao P; Gao YQ
    World J Gastroenterol; 2016 May; 22(18):4585-93. PubMed ID: 27182168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: current treatment options and management of functional dyspepsia.
    Lacy BE; Talley NJ; Locke GR; Bouras EP; DiBaise JK; El-Serag HB; Abraham BP; Howden CW; Moayyedi P; Prather C
    Aliment Pharmacol Ther; 2012 Jul; 36(1):3-15. PubMed ID: 22591037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of eradication of Cag A Helicobacter pylori in non ulcer dyspepsia.
    Babu V; Kate V; Ananthakrishnan N
    Trop Gastroenterol; 2005; 26(4):211-4. PubMed ID: 16737055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori eradication versus prokinetics in the treatment of functional dyspepsia: a randomized, double-blind study.
    Ang TL; Fock KM; Teo EK; Chan YH; Ng TM; Chua TS; Tan JY
    J Gastroenterol; 2006 Jul; 41(7):647-53. PubMed ID: 16933001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What role does Helicobacter pylori play in dyspepsia and nonulcer dyspepsia? Arguments for and against H. pylori being associated with dyspeptic symptoms.
    Talley NJ; Hunt RH
    Gastroenterology; 1997 Dec; 113(6 Suppl):S67-77. PubMed ID: 9394764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New developments in the treatment of functional dyspepsia.
    Stanghellini V; De Ponti F; De Giorgio R; Barbara G; Tosetti C; Corinaldesi R
    Drugs; 2003; 63(9):869-92. PubMed ID: 12678573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological interventions for non-ulcer dyspepsia.
    Moayyedi P; Soo S; Deeks J; Delaney B; Innes M; Forman D
    Cochrane Database Syst Rev; 2003; (1):CD001960. PubMed ID: 12535421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyspepsia: organic versus functional.
    Oustamanolakis P; Tack J
    J Clin Gastroenterol; 2012 Mar; 46(3):175-90. PubMed ID: 22327302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.